Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 10, 2016 5:27 PM ET

Life Sciences Tools and Services

Company Overview of Neogenomics Inc.

Executive Profile

Raymond R. Hipp

Independent Director, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee, Neogenomics Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 4 different industries.

See Board Relationships
72$71,025

Background

Mr. Raymond R. Hipp has been a Strategic Alternative and Merger & Acquisition Consultant since July 2002. Mr. Hipp served as the Chairman of the Board and President of ITI Marketing Services Inc., since July 1996 until May 1998. Mr. Hipp served as the Chairman, President and Chief Executive Officer of Alternative Resources Corporation ('ARC'), from July 1998 to June 2002. From August 1996 to May 1998, He was a self-employed management consultant from September 1994 to ...

Corporate Headquarters

12701 Commonwealth Drive
Fort Myers, Florida 33913

United States

Phone: 239-768-0600
Fax: 239-690-4237

Board Members Memberships

Director
1998-Present
Director and Member of Audit & Finance Committee
2011-Present
Independent Director, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee

Education

BS
Southeast Missouri State University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$61,875
Total Calculated Compensation$71,025
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Elazar Rabbani Ph.D.Co-Founder, Chairman, Chief Executive Officer and Secretary
Enzo Biochem Inc.
$555.5K
Raymond C. Kubacki Jr.Chairman, Chief Executive Officer and President
Psychemedics Corp.
$536.9K
Kenneth A. Berlin Chief Executive Officer and President
Rosetta Genomics, Ltd.
$800.0K
Panna Sharma Chief Executive Officer, President and Director
Cancer Genetics, Inc.
$600.0K
Michael J. Pellini M.D., MBAChief Executive Officer and Director
Foundation Medicine, Inc.
$416.0K
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Neogenomics Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.